1. Home
  2. VRNS vs IRTC Comparison

VRNS vs IRTC Comparison

Compare VRNS & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Varonis Systems Inc.

VRNS

Varonis Systems Inc.

HOLD

Current Price

$46.09

Market Cap

4.8B

Sector

Technology

ML Signal

HOLD

Logo iRhythm Technologies Inc.

IRTC

iRhythm Technologies Inc.

HOLD

Current Price

$123.07

Market Cap

4.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRNS
IRTC
Founded
2004
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8B
4.2B
IPO Year
2013
2016

Fundamental Metrics

Financial Performance
Metric
VRNS
IRTC
Price
$46.09
$123.07
Analyst Decision
Buy
Strong Buy
Analyst Count
21
13
Target Price
$42.75
$197.92
AVG Volume (30 Days)
1.4M
612.7K
Earning Date
04-28-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
61.71
EPS
N/A
N/A
Revenue
$270,288,000.00
$747,138,000.00
Revenue This Year
$18.87
$19.60
Revenue Next Year
$17.77
$15.94
P/E Ratio
N/A
N/A
Revenue Growth
24.35
26.24
52 Week Low
$19.70
$100.85
52 Week High
$63.90
$210.01

Technical Indicators

Market Signals
Indicator
VRNS
IRTC
Relative Strength Index (RSI) 58.67 52.76
Support Level $31.32 $112.26
Resistance Level $49.54 $129.48
Average True Range (ATR) 2.01 5.52
MACD 0.37 -0.33
Stochastic Oscillator 74.55 54.95

Price Performance

Historical Comparison
VRNS
IRTC

About VRNS Varonis Systems Inc.

Varonis Systems is a cybersecurity vendor focused on data privacy and security. The firm is currently undergoing a cloud transition as it weans its on-premises customers over to its cloud products that are delivered as software-as-a-service. The New York-based firm was founded in 2005 and went public in 2014.

About IRTC iRhythm Technologies Inc.

iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.

Share on Social Networks: